Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Bergot

Showing results (41-50 of 93) with videos related to

Pageof 10
Sort By:
Cell Death Discovery|December 13, 2025
NDR2 regulates non-small cell lung cancer cell migration under starvation by supporting autophagosome biogenesis through LC3 and ATG9A regulationTiphaine Biojout, Emmanuel Bergot, Jasmine Taylor, et al.
Plos One|October 29, 2025
Start up: A French program to support patients with pulmonary arterial hypertension during the adjustment of prostanoids to the individualized optimal doseEmmanuel Bergot, Marie Fertin, Mélanie Gallant Dewavrin, et al.
Current Oncology (Toronto, Ont.)|December 13, 2021
Contribution of the Idylla<sup>TM</sup> System to Improving the Therapeutic Care of Patients with NSCLC through Early Screening of <i>EGFR</i> MutationsConstance Petiteau, Gwladys Robinet-Zimmermann, Adèle Riot, et al.
The European Respiratory Journal|May 1, 2020
Initial combination therapy of macitentan and tadalafil in pulmonary arterial hypertensionOlivier Sitbon, Vincent Cottin, Matthieu Canuet, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|July 19, 2011
Myocardial strain assessment in cystic fibrosisFabien Labombarda, Arnaud Pellissier, Madiha Ellafi, et al.
International Journal of Cardiology|February 18, 2014
Current epoprostenol use in patients with severe idiopathic, heritable or anorexigen-associated pulmonary arterial hypertension: data from the French pulmonary hypertension registryEmmanuel Bergot, Olivier Sitbon, Vincent Cottin, et al.
The European Respiratory Journal|September 29, 2012
In vivo probe-based confocal laser endomicroscopy in amiodarone-related pneumoniaMathieu Salaün, Francis Roussel, Geneviève Bourg-Heckly, et al.
American Heart Journal|January 21, 2014
EPITOME-2: An open-label study assessing the transition to a new formulation of intravenous epoprostenol in patients with pulmonary arterial hypertensionOlivier Sitbon, Marion Delcroix, Emmanuel Bergot, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 17, 2012
Plasma cell membrane localization of c-MET predicts longer survival in patients with malignant mesothelioma: a series of 157 cases from the MESOPATH GroupGuénaëlle Levallet, Mélissa Vaisse-Lesteven, Nolwenn Le Stang, et al.
The European Respiratory Journal|March 15, 2014
Upfront triple combination therapy in pulmonary arterial hypertension: a pilot studyOlivier Sitbon, Xavier Jaïs, Laurent Savale, et al.
Pageof 10

Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
Cell Death Discovery|December 13, 2025
NDR2 regulates non-small cell lung cancer cell migration under starvation by supporting autophagosome biogenesis through LC3 and ATG9A regulationTiphaine Biojout, Emmanuel Bergot, Jasmine Taylor, et al.
Plos One|October 29, 2025
Start up: A French program to support patients with pulmonary arterial hypertension during the adjustment of prostanoids to the individualized optimal doseEmmanuel Bergot, Marie Fertin, Mélanie Gallant Dewavrin, et al.
Current Oncology (Toronto, Ont.)|December 13, 2021
Contribution of the Idylla<sup>TM</sup> System to Improving the Therapeutic Care of Patients with NSCLC through Early Screening of <i>EGFR</i> MutationsConstance Petiteau, Gwladys Robinet-Zimmermann, Adèle Riot, et al.
The European Respiratory Journal|May 1, 2020
Initial combination therapy of macitentan and tadalafil in pulmonary arterial hypertensionOlivier Sitbon, Vincent Cottin, Matthieu Canuet, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|July 19, 2011
Myocardial strain assessment in cystic fibrosisFabien Labombarda, Arnaud Pellissier, Madiha Ellafi, et al.
International Journal of Cardiology|February 18, 2014
Current epoprostenol use in patients with severe idiopathic, heritable or anorexigen-associated pulmonary arterial hypertension: data from the French pulmonary hypertension registryEmmanuel Bergot, Olivier Sitbon, Vincent Cottin, et al.
The European Respiratory Journal|September 29, 2012
In vivo probe-based confocal laser endomicroscopy in amiodarone-related pneumoniaMathieu Salaün, Francis Roussel, Geneviève Bourg-Heckly, et al.
American Heart Journal|January 21, 2014
EPITOME-2: An open-label study assessing the transition to a new formulation of intravenous epoprostenol in patients with pulmonary arterial hypertensionOlivier Sitbon, Marion Delcroix, Emmanuel Bergot, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 17, 2012
Plasma cell membrane localization of c-MET predicts longer survival in patients with malignant mesothelioma: a series of 157 cases from the MESOPATH GroupGuénaëlle Levallet, Mélissa Vaisse-Lesteven, Nolwenn Le Stang, et al.
The European Respiratory Journal|March 15, 2014
Upfront triple combination therapy in pulmonary arterial hypertension: a pilot studyOlivier Sitbon, Xavier Jaïs, Laurent Savale, et al.
Pageof 10